Cardinal Health (CAH) Stock Price

Cardinal Health Price

NYSE·CLOSED
230.03USD+2.96 (+1.30 %)
Market closed

Over the last 19 years Cardinal Health grew revenue by 5.6% annually, reaching 222.58 B USD. Earnings per share have grown at 5.4% per year over the last 19 years. For Cardinal Health, the net margin of 0.7% is broadly stable versus 0.4% a few years ago. At today's price the dividend yield works out to roughly 0.88%. The payout ratio is around 31% of earnings. The dividend has grown at 10.0% per year over the past 19 years. The consensus 12-month price target for Cardinal Health is 244.80 USD, about 6.4% above where the stock trades today. Of 22 analysts, 19 rate the stock a buy — an overall Buy consensus. The stock trades about 58% above its 52-week low.

Cardinal Health stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Cardinal Health over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Cardinal Health stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Cardinal Health's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Cardinal Health Stock Price History
DateCardinal Health Price
7/31/2026230.03 USD
7/30/2026227.07 USD
7/29/2026233.03 USD
7/27/2026230.04 USD
7/23/2026225.98 USD
7/22/2026220.54 USD
7/21/2026227.09 USD
7/20/2026225.75 USD
7/17/2026228.52 USD
7/16/2026228.72 USD
7/15/2026224.94 USD
7/14/2026230.11 USD
7/13/2026233.82 USD
7/10/2026235.80 USD
7/9/2026233.77 USD
7/8/2026239.13 USD
7/7/2026239.71 USD
7/6/2026235.50 USD
7/2/2026238.94 USD
7/1/2026237.72 USD
6/30/2026237.56 USD
6/29/2026238.99 USD
6/26/2026237.92 USD
6/25/2026234.75 USD
6/24/2026233.01 USD
6/23/2026228.91 USD
6/22/2026224.59 USD
6/18/2026220.98 USD
6/17/2026226.35 USD
6/16/2026227.87 USD
6/15/2026224.75 USD
6/12/2026223.55 USD
6/11/2026221.85 USD
6/10/2026216.74 USD
6/9/2026212.67 USD
6/8/2026204.48 USD
6/5/2026206.72 USD
6/4/2026201.01 USD
6/3/2026195.98 USD
6/2/2026195.43 USD
6/1/2026195.37 USD
5/29/2026199.12 USD
5/28/2026199.07 USD
5/27/2026201.05 USD
5/26/2026200.45 USD
5/22/2026200.28 USD
5/21/2026199.90 USD
5/20/2026199.51 USD
5/19/2026200.37 USD
5/18/2026199.77 USD
5/15/2026195.20 USD
5/14/2026194.38 USD
5/13/2026186.35 USD
5/12/2026182.56 USD
5/11/2026182.50 USD
5/8/2026183.65 USD
5/7/2026185.28 USD
5/6/2026191.49 USD
5/5/2026197.00 USD
5/4/2026197.06 USD
5/1/2026195.24 USD
4/30/2026192.88 USD
4/29/2026202.82 USD
4/28/2026205.61 USD
4/27/2026202.34 USD
4/24/2026199.85 USD
4/23/2026204.72 USD
4/22/2026200.55 USD
4/21/2026204.92 USD
4/20/2026211.18 USD
4/17/2026213.99 USD
4/16/2026213.10 USD
4/15/2026211.83 USD
4/14/2026214.95 USD
4/13/2026214.18 USD
4/10/2026215.52 USD
4/9/2026215.80 USD
4/8/2026215.13 USD
4/7/2026212.77 USD
4/6/2026212.62 USD
4/2/2026214.05 USD
4/1/2026212.02 USD
3/31/2026211.31 USD
3/30/2026206.31 USD
3/27/2026206.58 USD
3/26/2026208.02 USD
3/25/2026214.02 USD
3/24/2026207.23 USD
3/23/2026206.62 USD
3/20/2026209.02 USD
3/19/2026214.22 USD
3/18/2026210.92 USD
3/17/2026216.02 USD
3/16/2026217.59 USD
3/13/2026217.08 USD
3/12/2026219.09 USD
3/11/2026214.97 USD
3/10/2026217.04 USD
3/9/2026222.28 USD
3/6/2026219.13 USD
3/5/2026216.02 USD
3/4/2026223.18 USD
3/3/2026226.35 USD
3/2/2026229.88 USD
2/27/2026229.23 USD
2/26/2026227.13 USD
2/25/2026226.18 USD
2/24/2026225.97 USD
2/23/2026224.82 USD
2/20/2026224.44 USD
2/19/2026222.76 USD
2/18/2026224.99 USD
2/17/2026225.58 USD
2/16/2026225.58 USD
2/13/2026220.79 USD
2/12/2026220.79 USD
2/11/2026215.06 USD
2/10/2026224.25 USD
2/9/2026220.27 USD
2/8/2026225.76 USD
2/6/2026226.32 USD
2/5/2026226.32 USD
2/4/2026227.18 USD
2/3/2026206.85 USD
2/2/2026218.00 USD
2/1/2026218.93 USD
1/30/2026214.88 USD
1/29/2026214.88 USD
1/28/2026211.23 USD
1/27/2026210.39 USD
1/26/2026214.04 USD
1/25/2026210.93 USD
1/23/2026208.33 USD
1/22/2026208.33 USD
1/21/2026206.89 USD
1/20/2026208.47 USD
1/19/2026210.37 USD
1/16/2026212.45 USD
1/15/2026212.45 USD
1/14/2026213.46 USD
1/13/2026213.56 USD
1/12/2026208.26 USD
1/11/2026202.52 USD
1/9/2026201.11 USD
1/8/2026201.11 USD
1/7/2026202.49 USD
1/6/2026207.19 USD
1/5/2026208.48 USD
1/4/2026205.45 USD
1/2/2026205.72 USD
1/1/2026205.72 USD
12/31/2025205.50 USD
12/30/2025205.50 USD
12/29/2025207.21 USD
12/28/2025207.38 USD
12/26/2025208.29 USD
12/25/2025208.29 USD
12/24/2025207.54 USD
12/23/2025207.54 USD
12/22/2025207.37 USD
12/21/2025205.20 USD
12/19/2025202.95 USD
12/18/2025202.95 USD
12/17/2025199.10 USD
12/16/2025198.44 USD
12/15/2025197.89 USD
12/14/2025199.96 USD
12/12/2025198.18 USD
12/11/2025198.18 USD
12/10/2025198.32 USD
12/9/2025198.21 USD
12/8/2025198.00 USD
12/7/2025198.88 USD
12/5/2025198.83 USD
12/4/2025198.83 USD
12/3/2025199.19 USD
12/2/2025199.71 USD
12/1/2025205.13 USD
11/30/2025208.00 USD
11/28/2025212.26 USD
11/27/2025212.26 USD
11/26/2025213.14 USD
11/25/2025213.14 USD
11/24/2025213.73 USD
11/23/2025211.20 USD
11/21/2025209.48 USD
11/20/2025209.48 USD
11/19/2025207.90 USD
11/18/2025207.52 USD
11/17/2025206.97 USD
11/16/2025206.18 USD
11/14/2025205.37 USD
11/13/2025205.37 USD
11/12/2025206.06 USD
11/11/2025204.32 USD
11/10/2025204.81 USD
11/9/2025205.43 USD
11/7/2025203.67 USD
11/6/2025203.67 USD
11/5/2025197.99 USD
11/4/2025196.79 USD
11/3/2025195.34 USD
11/2/2025190.22 USD
10/31/2025190.77 USD
10/30/2025190.77 USD
10/29/2025189.84 USD
10/28/2025164.47 USD
10/27/2025162.79 USD
10/26/2025163.80 USD
10/23/2025161.89 USD
10/22/2025159.16 USD
10/21/2025159.52 USD
10/20/2025158.68 USD
10/19/2025157.27 USD
10/16/2025156.41 USD
10/15/2025153.27 USD
10/14/2025155.67 USD
10/13/2025154.19 USD
10/12/2025154.31 USD
10/9/2025156.88 USD
10/8/2025157.21 USD
10/7/2025157.77 USD
10/6/2025156.65 USD
10/5/2025155.19 USD
10/2/2025154.46 USD
10/1/2025158.46 USD
9/30/2025157.93 USD
9/29/2025156.96 USD
9/28/2025154.57 USD
9/25/2025153.71 USD
9/24/2025148.96 USD
9/23/2025154.58 USD
9/22/2025154.62 USD
9/21/2025147.47 USD
9/18/2025149.60 USD
9/17/2025150.04 USD
9/16/2025148.68 USD
9/15/2025148.37 USD
9/14/2025150.27 USD
9/11/2025152.24 USD
9/10/2025152.47 USD
9/9/2025149.29 USD
9/8/2025150.94 USD
9/7/2025150.28 USD
9/4/2025149.56 USD
9/3/2025149.34 USD
9/2/2025150.56 USD
9/1/2025149.55 USD
8/28/2025148.78 USD
8/27/2025149.51 USD
8/26/2025149.24 USD
8/25/2025147.49 USD
8/24/2025146.04 USD
8/21/2025148.10 USD
8/20/2025151.57 USD
8/19/2025152.95 USD
8/18/2025149.02 USD
8/17/2025149.73 USD
8/14/2025149.61 USD
8/13/2025150.22 USD
8/12/2025148.12 USD
8/11/2025146.30 USD
8/10/2025157.66 USD
8/7/2025157.41 USD
8/6/2025153.41 USD
8/5/2025156.60 USD
8/4/2025158.24 USD
Access this data via the Eulerpool API
Get Free API Key

Cardinal Health Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
204.98 B USD
752.00 M USD
330.00 M USD
Jan 1, 2024
226.83 B USD
1.24 B USD
852.00 M USD
Jan 1, 2025
222.58 B USD
2.28 B USD
1.56 B USD
Jan 1, 2026 (e)
255.87 B USD
5.65 B USD
2.61 B USD
Jan 1, 2027 (e)
275.63 B USD
6.09 B USD
2.92 B USD
Jan 1, 2028 (e)
297.85 B USD
6.58 B USD
3.29 B USD
Jan 1, 2029 (e)
322.24 B USD
7.12 B USD
3.70 B USD
Jan 1, 2030 (e)
339.03 B USD
7.49 B USD
4.29 B USD

Cardinal Health Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 4, 2026, 9:51 AM
 
REVENUEB USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB USD
EBITB USD
EBIT MARGIN%
NET INCOMEB USD
NET INCOME GROWTH%
DIV.USD
DIV. GROWTH%
SHARESM
201520162017201820192020202120222023202420252026e2027e2028e2029e2030e
102.53121.55129.98136.81145.53152.92162.47181.33204.98226.83222.58255.87275.63297.85322.24339.03
12.5718.556.945.266.385.086.2411.6113.0410.66-1.8714.967.728.068.195.21
5.575.385.035.254.704.494.173.583.363.273.673.673.673.673.673.67
5.716.546.547.186.836.876.786.486.897.418.179.3910.1110.9311.8312.44
2.162.462.120.132.06-4.100.47-0.640.751.242.285.656.096.587.127.49
2.112.021.630.091.42-2.680.29-0.350.370.551.022.212.212.212.212.21
1.221.431.290.261.36-3.690.61-0.940.330.851.562.612.923.293.704.29
4.2017.45-9.74-80.12432.42-370.95-116.54-253.52-135.18158.1883.2267.0112.0412.5312.4116.02
1.502.182.301.891.921.941.961.982.001.512.032.042.062.08––
-10.1845.335.50-17.831.591.041.031.021.01-24.5034.440.490.980.97––
332.00319.00316.00300.00294.00295.00281.00261.00246.00243.00237.00237.00237.00237.00237.00237.00
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Cardinal Health generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Cardinal Health retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Cardinal Health's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Cardinal Health has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Cardinal Health's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Cardinal Health stock margins

The Cardinal Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Cardinal Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Cardinal Health.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
4.17 %
0.29 %
0.38 %
Jan 1, 2022
3.58 %
-0.35 %
-0.52 %
Jan 1, 2023
3.36 %
0.37 %
0.16 %
Jan 1, 2024
3.27 %
0.55 %
0.38 %
Jan 1, 2025
3.67 %
1.02 %
0.70 %
Jan 1, 2026 (e)
3.67 %
2.21 %
1.02 %
Jan 1, 2027 (e)
3.67 %
2.21 %
1.06 %
Jan 1, 2028 (e)
3.67 %
2.21 %
1.10 %

Cardinal Health Stock Revenue, EBIT, Earnings per Share

The Cardinal Health earnings per share therefore indicates how much revenue Cardinal Health has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
578.17 USD
1.68 USD
2.17 USD
Jan 1, 2022
694.74 USD
-2.44 USD
-3.59 USD
Jan 1, 2023
833.25 USD
3.06 USD
1.34 USD
Jan 1, 2024
933.44 USD
5.12 USD
3.51 USD
Jan 1, 2025
939.15 USD
9.60 USD
6.59 USD
Jan 1, 2026 (e)
1,057.30 USD
23.85 USD
10.78 USD
Jan 1, 2027 (e)
1,138.96 USD
25.69 USD
12.07 USD
Jan 1, 2028 (e)
1,230.77 USD
27.76 USD
13.59 USD

Cardinal Health business model & stock analysis

Cardinal Health Inc. is an American company operating in the healthcare sector. It was founded in 1971 and is headquartered in Dublin, Ohio. Cardinal Health's business model is based on manufacturing and distributing medical products and services that cover the entire spectrum of healthcare. The company is divided into three business segments: pharmaceutical, medical, and laboratory products. Cardinal Health offers a wide range of products, including prescription medications, medical devices, and laboratory supplies. It has become a major supplier to healthcare providers worldwide.

Cardinal Health SWOT Analysis

Strengths

1. Extensive distribution network facilitating efficient supply chain management.

2. Diversified product portfolio including pharmaceuticals, medical and surgical products.

3. Strong brand reputation and recognition in the healthcare industry.

4. Well-established relationships with various healthcare providers.

5. Ability to leverage technology to enhance operational efficiency.

Weaknesses

1. Dependence on a limited number of large customers for a significant portion of revenue.

2. Vulnerability to changes in government regulations and reimbursement policies.

3. Reliance on external suppliers for raw materials and finished products.

4. High competition within the healthcare distribution industry.

5. Occasional product recalls impacting customer trust.

Opportunities

1. Growing demand for healthcare services due to aging population and increasing chronic diseases.

2. Expansion into emerging markets with evolving healthcare systems.

3. Strategic partnerships and acquisitions to enhance market presence and diversify offerings.

4. Adoption of advanced technologies and data analytics for improved efficiency and patient care.

5. Increasing focus on personalized medicine and home healthcare.

Threats

1. Intense competition from other healthcare distributors and manufacturers.

2. Cost containment measures in the healthcare industry impacting profit margins.

3. Economic downturns affecting customer spending on healthcare products.

4. Legal and regulatory risks associated with the healthcare industry.

5. Potential disruptions in the global supply chain due to geopolitical events or natural disasters.

Cardinal Health Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Cardinal Health Employees
Details
Date
Cardinal Health Employees
Jan 1, 2018
- Employees
Jan 1, 2019
- Employees
Jan 1, 2020
- Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees

Cardinal Health Segments

Cardinal Health Revenue by Segment (1/6)

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

Medical
Details
Date
Total Segment Profit
Pharmaceutical
Medical
Corporate
Jan 1, 2012
107.57 B USD
97.93 B USD
9.64 B USD
-15.00 M USD
Jan 1, 2013
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2014
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2015
0.00 USD
0.00 USD
11.40 B USD
0.00 USD

Cardinal Health Revenue by Segment (2/6)

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

Pharmaceutical
Details
Date
Pharmaceutical
Jan 1, 2012
0.00 USD
Jan 1, 2013
91.10 B USD
Jan 1, 2014
80.11 B USD
Jan 1, 2015
91.12 B USD

Cardinal Health Revenue by Segment (3/6)

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

Medical
Corporate
Details
Date
Medical
Corporate
Jan 1, 2012
0.00 USD
0.00 USD
Jan 1, 2013
0.00 USD
0.00 USD
Jan 1, 2014
10.96 B USD
0.00 USD
Jan 1, 2015
0.00 USD
20.00 M USD

Cardinal Health Revenue by Segment (4/6)

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

Reportable Segments
Medical
Corporate
Details
Date
Reportable Segments
Medical
Corporate
Jan 1, 2012
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2013
0.00 USD
10.06 B USD
0.00 USD
Jan 1, 2014
0.00 USD
0.00 USD
12.00 M USD
Jan 1, 2015
102.51 B USD
0.00 USD
0.00 USD

Cardinal Health Revenue by Segment (5/6)

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

Reportable Segments
Corporate
Details
Date
Reportable Segments
Corporate
Jan 1, 2012
0.00 USD
0.00 USD
Jan 1, 2013
0.00 USD
-64.00 M USD
Jan 1, 2014
91.07 B USD
0.00 USD
Jan 1, 2015
0.00 USD
0.00 USD

Cardinal Health Revenue by Segment (6/6)

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

Reportable Segment
Details
Date
Reportable Segment
Jan 1, 2012
0.00 USD
Jan 1, 2013
101.16 B USD
Jan 1, 2014
0.00 USD
Jan 1, 2015
0.00 USD

Cardinal Health Revenue by Region

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

United States
International
Other Countries
Details
Date
United States
International
Other Countries
Jan 1, 2018
132.53 B USD
4.28 B USD
0.00 USD
Jan 1, 2019
141.48 B USD
0.00 USD
4.07 B USD
Jan 1, 2020
148.71 B USD
4.23 B USD
0.00 USD
Jan 1, 2021
157.76 B USD
0.00 USD
4.73 B USD
Jan 1, 2022
176.86 B USD
0.00 USD
4.52 B USD
Jan 1, 2023
200.38 B USD
0.00 USD
4.64 B USD
Jan 1, 2024
225.23 B USD
0.00 USD
1.68 B USD
Jan 1, 2025
220.99 B USD
0.00 USD
1.67 B USD

Cardinal Health Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Cardinal Health historical P/E ratio, EBIT multiple, and P/S ratio

Cardinal Health annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Cardinal Health shares outstanding

The number of shares of Cardinal Health was 237 M in 2025. This indicates how many shares Cardinal Health is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
281.00 M Stocks
Jan 1, 2022
261.00 M Stocks
Jan 1, 2023
246.00 M Stocks
Jan 1, 2024
243.00 M Stocks
Jan 1, 2025
237.00 M Stocks
Jan 1, 2026 (e)
237.00 M Stocks
Jan 1, 2027 (e)
237.00 M Stocks
Jan 1, 2028 (e)
237.00 M Stocks

Cardinal Health stock splits

In Cardinal Health's history, there have been no stock splits.

Cardinal Health Dividend History

38 years of dividend payments

YearAnnual DividendYoY ChangePayments
20261.02USDYTD—2×
Jan 2, 20260.51USD 0.0%1/2
Apr 1, 20260.51USD 0.0%2/2
20252.03USD↑ 34.4%4×
Jan 2, 20250.51USD 0.0%1/4
Apr 1, 20250.51USD 0.0%2/4
Jul 1, 20250.51USD↑ 1.0%3/4
Oct 1, 20250.51USD 0.0%4/4
20241.51USD↓ 24.3%3×
20232.00USD↑ 1.0%4×
20221.98USD↑ 1.0%4×
20211.96USD↑ 1.0%4×
20201.94USD↑ 1.0%4×
20191.92USD↑ 1.5%4×
20181.89USD↓ 17.7%4×
20172.30USD↑ 5.3%5×

Cardinal Health dividend history and estimates

In 2025, Cardinal Health paid a dividend amounting to 2.03 USD. Dividend means that Cardinal Health distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2021
1.96 USD
0.00 USD
Jan 1, 2022
1.98 USD
0.00 USD
Jan 1, 2023
2.00 USD
0.00 USD
Jan 1, 2024
1.51 USD
0.00 USD
Jan 1, 2025
2.03 USD
0.00 USD
Jan 1, 2026 (e)
1.53 USD
0.51 USD
Jan 1, 2027 (e)
0.00 USD
2.06 USD
Jan 1, 2028 (e)
0.00 USD
2.08 USD

Cardinal Health dividend payout ratio

In 2025, Cardinal Health had a payout ratio of 30.86%. The payout ratio indicates the percentage of the company's profits that Cardinal Health distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
90.06 %
Jan 1, 2022
-55.04 %
Jan 1, 2023
148.90 %
Jan 1, 2024
43.12 %
Jan 1, 2025
30.86 %
Jan 1, 2026 (e)
18.96 %
Jan 1, 2027 (e)
17.09 %
Jan 1, 2028 (e)
15.34 %

Current Cardinal Health forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
7.62 %
Buy
86.36 % (19)
Hold
13.64 % (3)
Sell
0.00 % (0)
12M Price Target
244.80
Last Price
230.03
Currency
USD
12M Return Potential
6.42 %
LTM Return
0 %

Cardinal Health Analyst Rating Actions

DateFirmActionRatingReliability
7/24/2026
Citigroup
Citigroup
MaintainedBuy48
7/23/2026
Mizuho
Mizuho
MaintainedOutperform31
7/20/2026
UBS
UBS
MaintainedBuy51
7/9/2026
TD Cowen
TD Cowen
MaintainedBuy60
7/2/2026
B of A Securities
B of A Securities
MaintainedBuy70
5/4/2026
JP Morgan
JP Morgan
MaintainedNeutral80
5/1/2026
Wells Fargo
Wells Fargo
MaintainedOverweight56
5/1/2026
TD Cowen
TD Cowen
MaintainedBuy60
5/1/2026
Citigroup
Citigroup
MaintainedBuy48
4/8/2026
Evercore ISI Group
Evercore ISI Group
MaintainedOutperform62

Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.

Cardinal Health Earnings Calls

2025

Cardinal Health Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
8/11/20262.44USD-65.68 BUSD-2026 Q4
4/30/20262.80USD-62.33 BUSD-2026 Q3
2/5/20262.38USD-64.79 BUSD-2026 Q2
8/12/20252.06USD-61.48 BUSD-2025 Q4
5/2/20241.91USD-56.47 BUSD-2024 Q3
1/31/20241.61USD-57.63 BUSD-2024 Q2
8/9/20231.54USD-53.15 BUSD-2023 Q4
5/3/20231.53USD-50.31 BUSD-2023 Q3
2/1/20231.19USD-50.96 BUSD-2023 Q2
11/4/20220.95USD-48.91 BUSD-2023 Q1
...

EESG©

Eulerpool ESG Scorecard© for the Cardinal Health stock

90/100
93
Environment
85
Social
92
Governance
E

Environment

20
Scope 1 - Direct Emissions160,150
Scope 2 - Indirect emissions from purchased energy205,710
Scope 3 - Indirect emissions within the value chain22,437,666
Total CO₂ emissions365,860
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees51.1
Percentage of women in management—
Percentage of Asian employees9.7
Share of Asian management8.675
Percentage of Hispanic/Latino employees19.4
Hispano/Latino Management share8.675
Percentage of Black employees18.2
Black Management Share9.305
Percentage of white employees49.3
White Management Share70.708
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Cardinal Health shareholder structure

% Name
11.77473%
BLACKROCK, INC.
BLACKROCK, INC.
6.31765%
VANGUARD CAPITAL MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC
5.67451%
VANGUARD PORTFOLIO MANAGEMENT LLC
VANGUARD PORTFOLIO MANAGEMENT LLC
4.98947%
STATE STREET CORP
STATE STREET CORP
2.71923%
GEODE CAPITAL MANAGEMENT, LLC
GEODE CAPITAL MANAGEMENT, LLC
2.04724%
MORGAN STANLEY
MORGAN STANLEY
...

Cardinal Health Beneficial Ownership Filings (SEC 13D/G)

Free Float
99.8%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
12.72%
The Vanguard Group - 23-1945930
The Vanguard Group - 23-1945930
SEC ↗
11.59%
FMR Corp.
FMR Corp.
SEC ↗
11.59%
Edward C. Johnson 3d
Edward C. Johnson 3d
SEC ↗
11.59%
Abigail P. Johnson
Abigail P. Johnson
SEC ↗
11.10%
Dodge & Cox 94-1441976
Dodge & Cox 94-1441976
SEC ↗
10.60%
(1) BlackRock, Inc.
(1) BlackRock, Inc.
SEC ↗
9.66%
04-2683227
04-2683227
SEC ↗
9.10%
94-1441976
94-1441976
SEC ↗
7.80%
BlackRock, Inc.
BlackRock, Inc.
SEC ↗
7.59%
STATE STREET CORPORATION
STATE STREET CORPORATION
SEC ↗

Cardinal Health Executives and Management Board

19 members · avg. age 60 · 47 % women

JH

Mr. Jason Hollar (52)

Chief Executive Officer, Director · since 2020

18.98 M USD

Management

AA

Mr. Aaron Alt (53)

Chief Financial Officer

6.21 M USD
DW

Ms. Deborah Weitzman (60)

Chief Executive Officer of Pharmaceutical and Specialty Solutions Segment

5.51 M USD
JM

Ms. Jessica Mayer (56)

Chief Legal and Compliance Officer

4.93 M USD
SM

Mr. Stephen Mason (54)

Corporate Executive - GMPD segment

4.75 M USD
OS

Ms. Ola Snow (58)

Chief Human Resources Officer

–
MG

Ms. Michelle Greene (55)

Executive Vice President, Chief Information Officer, Customer Support Services

–

Board of Directors

GK

Mr. Gregory Kenny (72)

Independent Non-Executive Chairman of the Board

570,011.00 USD
AJ

Mr. Akhil Johri (64)

Independent Director

346,953.00 USD
PH

Ms. Patricia Hemingway Hall (72)

Independent Director

341,953.00 USD
SE

Ms. Sheri Edison (68)

Independent Director

339,953.00 USD
NK

Ms. Nancy Killefer (71)

Independent Director

339,953.00 USD
RA

Mr. Robert Azelby (57)

Independent Director

321,953.00 USD

Cardinal Health Supply Chain

Cardinal Health Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
30 companies
#Nameβ 1YTrend
1
Bristol-Myers Squibb
Supplier·Pharmaceuticals·US
0.59
-0.11
0.71
0.90
0.85
0.63
0.84
2
Antares Pharma
Supplier·Customer·Pharmaceuticals·US
0.70
0.28
0.37
0.72
0.72
0.57
—
3
Amgen
Supplier·Biotechnology·US
0.72
-0.62
0.75
0.88
0.90
0.56
0.95
4
Lantheus Holdings
Supplier·Health Care Equipment & Supplies·US
0.72
0.29
0.45
0.80
0.60
0.36
1.01
#Nameβ 1YTrend
1
Apria, Inc.
Customer·Health Care Providers & Services·US
—
-0.49
0.26
0.51
0.02
—
—
2
Virtusa Corporation
Supplier·Customer·US
0.86
0.12
0.63
0.62
—
—
—
3
Roche Holding AG
Supplier
0.75
0.82
0.49
-0.09
-0.15
—
—
4
Zhonghong Pulin Medical Products A
Supplier·Health Care Equipment & Supplies·CN
0.65
0.50
0
-0.56
-0.09
—
—
5
Organon
Supplier·Pharmaceuticals·US
0.62
-0.51
-0.45
0.46
0.01
—
—

Frequently asked questions about Cardinal Health

The business model of Cardinal Health Inc. revolves around providing essential services and solutions to healthcare organizations. As a renowned healthcare services and products company, Cardinal Health operates through various segments, including Pharmaceutical and Medical segments. The company distributes pharmaceuticals, medical and surgical products, along with offering innovative solutions and cost-effective services to healthcare providers. Cardinal Health also focuses on improving the efficiency and effectiveness of healthcare delivery, ultimately benefiting patients and healthcare professionals worldwide. With its extensive network and strong partnerships, Cardinal Health continues to excel in the healthcare industry and contribute to the overall well-being of communities.

Cardinal Health Inc is primarily active in the healthcare industry.

The main competitors of Cardinal Health Inc in the market include McKesson Corporation, AmerisourceBergen Corporation, and Owens & Minor Inc.

Cardinal Health Inc is a leading healthcare services and products company with a rich history and remarkable background. Established in 1971 in Dublin, Ohio, Cardinal Health initially focused on distributing pharmaceuticals to retail pharmacies. Over the years, it expanded its operations and services to include medical products, surgical supplies, and innovative healthcare technologies. Cardinal Health has gained extensive expertise in pharmaceutical sourcing, inventory management, and logistics, becoming a trusted partner in the healthcare industry. Today, it serves a diverse range of customers, including hospitals, pharmacies, clinics, and home healthcare providers. With its commitment to improving patient care and enhancing operational efficiency, Cardinal Health has established an impressive reputation within the healthcare sector.

Cardinal Health Inc has achieved several significant milestones throughout its history. One of its notable achievements includes being ranked #14 on the Fortune 500 list in 2020. The company has also been consistently recognized for its dedication to community involvement and sustainability efforts. In terms of its financial performance, Cardinal Health Inc has demonstrated consistent growth and profitability over the years. Moreover, the company has made strategic acquisitions and partnerships to expand its healthcare offerings and global reach. These milestones reflect Cardinal Health Inc's commitment to delivering innovative solutions and maintaining its position as a leader in the healthcare industry.

Cardinal Health Inc primarily operates in the United States.

Cardinal Health Inc represents values of integrity, excellence, and accountability in the healthcare industry. The company focuses on providing innovative solutions, quality products, and reliable services to meet the evolving needs of healthcare providers and patients. With a commitment to ethical business practices and corporate responsibility, Cardinal Health strives to improve the delivery of healthcare outcomes and enhance the overall well-being of communities. By fostering strong partnerships and embracing a patient-centric approach, Cardinal Health aims to drive positive change and improve the efficiency of healthcare operations.

Analysts currently set an average price target of 238.45 USD for the Cardinal Health stock (median: 244.80 USD), implying +3.7 % versus the latest price. The consensus is based on 22 analyst ratings.

Cardinal Health Analyst Price Targets 2026

22 analysts currently rate the Cardinal Health stock: 19 recommend buying, 3 holding and 0 selling. For 2026, analysts expect Cardinal Health to generate revenue of 255.87 B USD and earnings per share of 11.00 USD.

Cardinal Health Analyst Price Targets 2026

Converted at the current exchange rate, the Cardinal Health share trades at 199.83 EUR (230.03 USD).

The Cardinal Health share (CAH) is listed on 7 stock exchanges, including: NYSE (CAH), Frankfurt (CLH.F), München (CLH.MU), Düsseldorf (CLH.DU), London (0HTG.L), London (0HTG.L), SIX (Zürich) (CLH.SW).

The company Cardinal Health Inc is a pharmaceutical company that offers a wide range of services and products. The company is one of the leading healthcare providers worldwide and specializes in the areas of pharmacy, medical technology, and diagnostics. The company is particularly known for its pharmaceutical distribution services. Cardinal Health Inc supplies hospitals, pharmacies, and other healthcare facilities worldwide with pharmaceutical products. Additionally, the company also offers logistics and consulting services in the pharmaceutical industry. This includes support in the development and registration of pharmaceutical active ingredients as well as compliance consulting. Another pillar of the company is the development and manufacturing of medical products. Cardinal Health Inc offers a wide range of medical products, including consumables for medical applications and special medical technology. This includes devices for surgical procedures, diagnostic systems, and imaging systems. Another sector of Cardinal Health Inc is diagnostics. Under this area, the company offers a wide range of tests and analyses for medical facilities. This includes tests for cancer diagnostics, infection diagnostics, as well as determining genetic markers. The company places a strong emphasis on research and development. Cardinal Health Inc invests millions of dollars annually in the research and development of new products, as well as the improvement and optimization of existing products. The goal is always to offer customers innovative and future-oriented products. Another focus of the company is sustainability. Cardinal Health Inc aims to integrate sustainability and environmental protection into its daily business operations and to offer products and services that are not only economically but also environmentally and socially sustainable. Overall, Cardinal Health Inc offers a wide range of products and services for the pharmaceutical and medical industry. The different sectors complement each other optimally and enable the company to offer a comprehensive range. However, the company will continue to evolve and respond to the needs of customers in order to remain successful in the future.

The expected revenue of Cardinal Health is 255.87 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Cardinal Health is 2.61 B USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Cardinal Health is currently 20.90. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Cardinal Health stock.

The price-to-sales ratio (P/S) of Cardinal Health is currently 0.21. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Cardinal Health stock.

The Eulerpool Quality Score for Cardinal Health is 5/10.

The ISIN of Cardinal Health is US14149Y1082. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Cardinal Health is 880206. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Cardinal Health is CAH. The ticker symbol is used to trade Cardinal Health shares on the stock exchange.

Over the past 12 months, Cardinal Health paid a dividend of 2.03 USD . This corresponds to a dividend yield of about 0.88 %. For the coming 12 months, Cardinal Health is expected to pay a dividend of 2.06 USD.

The current dividend yield of Cardinal Health is 0.88 %.

Cardinal Health pays a dividend, distributed in the months of , , , .

Cardinal Health paid dividends every year for the past 37 years.

For the upcoming 12 months, dividends amounting to 2.06 USD are expected. This corresponds to a dividend yield of 0.90 %.

Cardinal Health is assigned to the 'Health' sector.

To receive the latest dividend of Cardinal Health from amounting to 0.51 USD, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, Cardinal Health distributed 2.01 USD as dividends.

The dividends of Cardinal Health are distributed in USD.

All fundamentals and in-depth analysis of Cardinal Health

Our stock analysis for Cardinal Health stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cardinal Health. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Cardinal Health Stock
Cardinal Health Revenue→
Cardinal Health Stock
Cardinal Health Net Income→
Cardinal Health Stock
Cardinal Health P/E→
Cardinal Health Stock
Cardinal Health P/S→
Cardinal Health Stock
Cardinal Health EBIT→
Cardinal Health Stock
Cardinal Health Dividend→
Cardinal Health Stock
Cardinal Health Directors Dealings→
Cardinal Health Stock
Cardinal Health Stocks→
Cardinal Health Stock
Cardinal Health Market capitalization→
Cardinal Health Stock
Cardinal Health Debt→
Cardinal Health Stock
Cardinal Health Liabilities→
Cardinal Health Stock
Cardinal Health Equity→
Cardinal Health Stock
Cardinal Health AAQS→
Cardinal Health Stock
Cardinal Health Employees→
Cardinal Health Stock
Cardinal Health ROE→
Cardinal Health Stock
Cardinal Health ROA→
Cardinal Health Stock
Cardinal Health ROCE→
Cardinal Health Stock
Cardinal Health News→
Cardinal Health Stock
Cardinal Health Analyst Price Targets→

Health Stocks

Cardio Diagnostics HoldingsCardiff OncologyCardioComm SolutionsCardaxCardioGenics HoldingsCaptor CapitalCardiol TherapeuticsCapstone HoldingCare Service CoCapsoVisionCare TwentyoneCapricor TherapeuticsAll Stocks A–Z →